Latest filings (excl ownership)
15-12G
Securities registration termination
13 Mar 23
25-NSE/A
Exchange delisting (amended)
2 Mar 23
8-K
Departure of Directors or Certain Officers
28 Feb 23
10-K
2022 FY
Annual report
27 Feb 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
21 Feb 23
DEFA14A
Additional proxy soliciting materials
14 Feb 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
13 Feb 23
DEFM14A
Proxy related to merger
3 Feb 23
UPLOAD
Letter from SEC
31 Jan 23
425
Business combination disclosure
30 Jan 23
8-K
Entry into a Material Definitive Agreement
30 Jan 23
UPLOAD
Letter from SEC
12 Jan 23
UPLOAD
Letter from SEC
20 Dec 22
425
Business combination disclosure
14 Dec 22
8-K
Regulation FD Disclosure
14 Dec 22
UPLOAD
Letter from SEC
2 Dec 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
F-4
Registration of securities (foreign)
7 Nov 22
8-K
Entry into a Material Definitive Agreement
17 Oct 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
31 Mar 22
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
22 Nov 21
10-Q
2021 Q3
Quarterly report
22 Nov 21
NT 10-Q
Notice of late quarterly filing
15 Nov 21
10-Q
2021 Q2
Quarterly report
18 Aug 21
NT 10-Q
Notice of late quarterly filing
16 Aug 21
10-Q
2021 Q1
Quarterly report
22 Jun 21
8-K
European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report
4 Jun 21
NT 10-Q
Notice of late quarterly filing
17 May 21
8-K
Unregistered Sales of Equity Securities
7 May 21
8-K
Other Events
4 May 21
8-K
Report of Independent Registered Public Accounting Firm
24 Mar 21
8-K
European Biotech Acquisition Corp. Announces Pricing of Upsized $120 Million Initial Public Offering
18 Mar 21
424B4
Prospectus supplement with pricing info
17 Mar 21
EFFECT
Notice of effectiveness
16 Mar 21
S-1MEF
Registration of additional securities for an S-1
15 Mar 21
S-1/A
IPO registration (amended)
15 Mar 21
CERT
Certification of approval for exchange listing
15 Mar 21
8-A12B
Registration of securities on exchange
12 Mar 21
Latest ownership filings
SC 13G
GLAZER CAPITAL, LLC
14 Feb 23
SC 13G
PERISCOPE CAPITAL INC.
13 Feb 23
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
6 Feb 23
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 22
SC 13G
LSP Sponsor EBAC B.V.
8 Feb 22
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
27 Jan 22
3
Mohammad Sohail Fazeli
14 May 21
SC 13G
CITADEL ADVISORS LLC
2 Apr 21
SC 13G
INTEGRATED CORE STRATEGIES (US) LLC
24 Mar 21
3
de Stolpe Onno van
15 Mar 21
3
Marcus Antonius Wegter
15 Mar 21
3
Martijn Kleijwegt
15 Mar 21
3
Sponsor EBAC B.V. LSP
15 Mar 21
3
Koen Sintnicolaas
15 Mar 21
3
de Araoz Eduardo Bravo Fernandez
15 Mar 21
3
Volkert H. Doeksen
15 Mar 21